Layers of Paperwork Slow Down Individualized Medications from Reaching Patients, Technology can Speed it Up

As originally reported in Quest Qunam and Sure Scripts; for manydiseases, time is of the essence in terms of treatment. The patient's health will deteriorate irreversibly thout treatment. However, with…

Continue Reading Layers of Paperwork Slow Down Individualized Medications from Reaching Patients, Technology can Speed it Up
IL-23 Inhibitors May be a Leading Treatment for Psoriasis and Psoriatic Arthritis
source: pixabay.com

IL-23 Inhibitors May be a Leading Treatment for Psoriasis and Psoriatic Arthritis

The 2019 European Academy of Dermatology and Venereology Congress was held in Madrid, Spain. During this conference, a symposium was held discussing IL-23 inhibition in psoriasis. Here are some of…

Continue Reading IL-23 Inhibitors May be a Leading Treatment for Psoriasis and Psoriatic Arthritis
Schizophrenia Patients in the United States Now Have a New Treatment Option
source: pixabay.com

Schizophrenia Patients in the United States Now Have a New Treatment Option

Schizophrenia patients in the United States now have a new treatment option. Intra-Cellular Therapies has just announced that their investigative therapy called CAPLYTA has received FDA approval for adult schizophrenia…

Continue Reading Schizophrenia Patients in the United States Now Have a New Treatment Option
Close Menu